Equity Profile

CTEV

Claritev Corporation

Health CareHealth Care Technology$428.2M

Aug6Thu

Pre-Earnings Brief

UpcomingQ2-2026Pre-Market9:00 AM EDT

Company Snapshot

Claritev Corporation operates in the health care technology sector, focusing on innovative solutions that improve patient care and streamline health services. As the health care industry increasingly adopts technology, Claritev's advancements could play a significant role in shaping how medical services are delivered.

Key Metrics to Watch

EPS (Earnings Per Share)

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

N/A

Revenue Growth

Revenue growth reflects the company's ability to expand its market presence and attract new customers, critical for long-term success.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

CTEV Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 5Q

EPS Beat Streak

EPS Beat Rate

Avg EPS Surprise

-51.72%

Avg Stock Reaction

+6.82%

Last Quarter Recap

In Q1-2026, Claritev reported an EPS of -$4.41, missing estimates by 15.75%. The stock reacted negatively, dropping 8.54% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Investors are cautious ahead of the earnings report, given the company's history of missing EPS estimates. The lack of guidance adds uncertainty to expectations.

Bull Case

If Claritev can demonstrate improved operational efficiency and better-than-expected revenue growth, it could signal a turnaround, boosting investor confidence.

Bear Case

Continued losses and failure to meet expectations could lead to further declines in stock price, as investors may lose faith in the company's recovery prospects.

Expectations

Two Questions That Matter

The print will turn on these two things.

What is the expected EPS for Q2-2026, and how does it compare to previous quarters?

Given the company's history of missing EPS estimates, any guidance on expected performance will be crucial for investor sentiment.

What specific strategies is Claritev implementing to improve revenue growth this quarter?

Investors will be looking for concrete plans that indicate how the company intends to turn around its financial performance.

Edge

What the Street Is Missing

Why consensus could be wrong

The market may be underestimating Claritev's potential for operational improvements, as recent investments in technology could yield better results than anticipated.

Supporting Evidence

The options market is pricing a high volatility move, indicating that traders expect significant changes in stock direction.

Claritev's historical performance shows that even after misses, the stock has occasionally rebounded strongly, suggesting potential for recovery.

Key Risk

If the company reports an EPS loss significantly lower than -$4.50, it could shift investor sentiment positively.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The core debate this quarter revolves around whether Claritev can demonstrate a path to profitability amid ongoing losses.

Bull Confirmed If

A reduction in EPS losses to below -$3.50 would indicate significant operational improvements.

Bear Confirmed If

If EPS remains above -$4.50, it would confirm ongoing struggles and could lead to further stock declines.

Pre-Earnings Positioning

Options Market

Implied Move

±57.32%

Historical Avg

±10.3%

Pricing rich

The options market is pricing in a significant potential move, indicating high uncertainty about the upcoming earnings report.

Options are pricing ±57.3% while CTEV has averaged ±10.3% over the last 5 prints — setup is pricing rich.

Detail

ATM IV

1.2%

30d HV

210.8%

Calls (4K)P/C Ratio: 0.43Puts (29K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter miss + options pricing rich setup in Health Care

n=30

Fade rate: 13 of 29 (45%)

This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 3.6%, with a raw directional average of -1.3% (modestly negative historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Claritev beats expectations, history suggests the stock could rise by an average of 6.82%, confirming a positive turnaround narrative.

In-Line / Cautious

If results are in line with expectations, the stock may see muted movement as investors weigh the potential for future growth.

Miss

A miss could lead to a decline of around 6.82%, reinforcing concerns about the company's financial health.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on cost-cutting measures and their expected impact on future EPS.
2Details on new product launches or partnerships that could drive revenue growth.
3Management's outlook on market conditions and competitive landscape in health care technology.
4Insights into customer acquisition strategies and retention rates.
5Any commentary on regulatory changes that could affect the business.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug3

ONBMO

ON Semiconductor Corporation

PreviewView

Aug3

LBMO

Company Snapshot

Key Metrics to Watch

EPS (Earnings Per Share)

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

N/A

Revenue Growth

Revenue growth reflects the company's ability to expand its market presence and attract new customers, critical for long-term success.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

CTEV Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 5Q

EPS Beat Streak

EPS Beat Rate

Avg EPS Surprise

-51.72%

Avg Stock Reaction

+6.82%

Last Quarter Recap

In Q1-2026, Claritev reported an EPS of -$4.41, missing estimates by 15.75%. The stock reacted negatively, dropping 8.54% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Investors are cautious ahead of the earnings report, given the company's history of missing EPS estimates. The lack of guidance adds uncertainty to expectations.

Bull Case

If Claritev can demonstrate improved operational efficiency and better-than-expected revenue growth, it could signal a turnaround, boosting investor confidence.

Bear Case

Continued losses and failure to meet expectations could lead to further declines in stock price, as investors may lose faith in the company's recovery prospects.

Expectations

Two Questions That Matter

The print will turn on these two things.

What is the expected EPS for Q2-2026, and how does it compare to previous quarters?

Given the company's history of missing EPS estimates, any guidance on expected performance will be crucial for investor sentiment.

What specific strategies is Claritev implementing to improve revenue growth this quarter?

Investors will be looking for concrete plans that indicate how the company intends to turn around its financial performance.

Edge

What the Street Is Missing

Why consensus could be wrong

The market may be underestimating Claritev's potential for operational improvements, as recent investments in technology could yield better results than anticipated.

Supporting Evidence

The options market is pricing a high volatility move, indicating that traders expect significant changes in stock direction.

Claritev's historical performance shows that even after misses, the stock has occasionally rebounded strongly, suggesting potential for recovery.

Key Risk

If the company reports an EPS loss significantly lower than -$4.50, it could shift investor sentiment positively.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The core debate this quarter revolves around whether Claritev can demonstrate a path to profitability amid ongoing losses.

Bull Confirmed If

A reduction in EPS losses to below -$3.50 would indicate significant operational improvements.

Bear Confirmed If

If EPS remains above -$4.50, it would confirm ongoing struggles and could lead to further stock declines.

Pre-Earnings Positioning

Options Market

Implied Move

±57.32%

Historical Avg

±10.3%

Pricing rich

The options market is pricing in a significant potential move, indicating high uncertainty about the upcoming earnings report.

Options are pricing ±57.3% while CTEV has averaged ±10.3% over the last 5 prints — setup is pricing rich.

Detail

ATM IV

1.2%

30d HV

210.8%

Calls (4K)P/C Ratio: 0.43Puts (29K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter miss + options pricing rich setup in Health Care

n=30

Fade rate: 13 of 29 (45%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Claritev beats expectations, history suggests the stock could rise by an average of 6.82%, confirming a positive turnaround narrative.

In-Line / Cautious

If results are in line with expectations, the stock may see muted movement as investors weigh the potential for future growth.

Miss

A miss could lead to a decline of around 6.82%, reinforcing concerns about the company's financial health.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on cost-cutting measures and their expected impact on future EPS.
2Details on new product launches or partnerships that could drive revenue growth.
3Management's outlook on market conditions and competitive landscape in health care technology.
4Insights into customer acquisition strategies and retention rates.
5Any commentary on regulatory changes that could affect the business.